HAHN MARK W (Chief Financial Officer) sold 7.9% of their position (775.00 shares) of DOVA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $21.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/2/2019ACC: 0001562180-19-005057
Officer· Chief Financial Officer
Since Oct 2018
-775.00
Net shares
Net seller
$21.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
775.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−775.00
Price / share
$28.00
Trade value
$21.70K
% of position
7.9%
9/30/2019
9.80K→9.02K
Total
Net shares
−775.00
Net value
-$21.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2019 | S · Sale | −775.00 | $28.00 | $21.70K | 7.9% | 9.80K | 9.02K |
| Total | −775.00 | -$21.70K | ||||||
Derivative Transactions0
No derivative transactions reported